Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
TYPES and FEATURES of Breast Cancer This handout describes the main types of breast cancer and some other ways of classifying breast cancer based on its features. Knowing the details of your cancer helps you and your doctor decide how to treat it. Your health care team is your primary resource for information. Only your health care team can give you medical advice about your treatment. For more information, ask your health care team or visit the websites listed at the end of the handout. Main Types of Breast Cancer The most common types of breast cancer, based on location, are described here. See page 2 for other important features that help to classify breast cancer. Ductal Carcinoma In Situ The Lymph System The body’s lymph system consists of lymph nodes (clusters of cells that help fight infection) connected by lymphatic vessels, which carry a fluid called lymph. Lymphatic vessels are located throughout the body and are one way that breast cancer cells can travel from the breast to other areas. Metastasis When invasive cancer enters blood or lymphatic vessels, it can spread (metastasize) beyond the breast. Ductal carcinoma in situ (DCIS) is the name for abnormal cells found inside a milk duct and still contained completely within the walls of the duct. (In situ means “in place.”) DCIS may be called a precancer. Because it has not spread to any nearby tissue, it is considered noninvasive. It sometimes develops into invasive cancer, but doctors cannot predict whether it will. DCIS is considered stage 0 (the earliest stage) and is highly curable. Lobular Carcinoma In Situ Ducts (tubes that carry milk) Lobules (glands that produce milk) Lobular carcinoma in situ (LCIS) is not a true cancer. It is the name for abnormal cells growing inside a milk-producing gland, or lobule, of the breast. LCIS is noninvasive and rarely becomes invasive, but women with LCIS are more likely than those without it to develop invasive cancer in either breast. Invasive Ductal Carcinoma Invasive ductal carcinoma (IDC) starts in a milk duct, and by the time it is diagnosed, it has spread through the wall of the duct into nearby breast tissue. Once this happens, it is possible for cancer cells to travel through blood vessels or the lymph system (see box) to other parts of the body. IDC is the most common type of breast cancer. Invasive Lobular Carcinoma Invasive lobular carcinoma (ILC) starts in a lobule of the breast. At the time of diagnosis, it has spread beyond the lobule to surrounding breast tissue, and there is a chance that it has also spread to other parts of the body. Less Common Types of Invasive Breast Cancer There are other types of invasive breast cancer that do not occur as often as IDC and ILC. One of these is inflammatory breast cancer, which can cause the breast to become swollen, tender, and red. Breast Cancer Grades Invasive breast cancer is called grade 1, 2, or 3 (low, intermediate, or high grade), depending on how much the cancer cells differ in appearance from normal cells. Grade 1 cancer cells look the most like normal cells. The grade of a cancer gives clues about its behavior; in general, the higher the grade, the faster the cancer is growing and the more likely it is to spread. Breast Cancer Stages Stage 0, the earliest stage, is carcinoma in situ, which is noninvasive. Stage I includes small tumors that may have spread to lymph nodes, but not to distant sites. Stage II includes larger tumors and those with more spread to the lymph nodes, but still no spread to distant sites. Stage III includes even larger tumors and those with extensive spread to lymph nodes, but still no spread to distant sites. Stage IV is metastatic cancer, meaning it has spread to distant organs or to lymph nodes far from the breast. Hormone Receptor–Positive or Hormone Receptor–Negative HER2-Positive or HER2-Negative Triple-Negative and Triple-Positive Some breast cancer cells have receptors that attach to the hormones estrogen and/or progesterone. These hormones can cause the cancer cells to grow. If your cancer has estrogen receptors or progesterone receptors, it is called hormone receptor–positive. If it has neither, it is hormone receptor– negative. Hormone receptor–positive cancer can be treated with drugs designed to lower the amount of hormones in your body or to prevent the receptors on cells from attaching to the hormones. The HER2 (human epidermal growth factor receptor 2) protein is another kind of receptor found on cells, and its job is to help cells grow. Some breast cancer cells have too many HER2 proteins, making the cancer grow faster than it would otherwise. If your cancer has a high number of HER2 proteins, it is called HER2positive. If it has a normal number, it is called HER2-negative. HER2positive breast cancer can be treated with drugs designed to block the HER2 protein’s ability to make cells grow. If your breast cancer has no estrogen receptors, no progesterone receptors, and no increased amount of HER2, it is called triple-negative. If it has all three of these features, it is called triple-positive. Triple-positive breast cancer can be treated with drugs for hormone receptor–positive cancer and with drugs for HER2-positive cancer (and also with conventional chemotherapy). These targeted drugs would not be appropriate for triplenegative breast cancer, but triplenegative cancer can still be treated with conventional chemotherapy. Doctors determine a breast cancer’s stage (how far it has progressed) by looking at the size of the tumor and how much the cancer has spread. Hormone Receptor and HER2 Status Laboratory tests can show whether your breast cancer has features that make it eligible for certain types of treatment. These targeted treatments are often given together with conventional chemotherapy, and they can affect both cancer cells and normal cells. Breast cell Progesterone Estrogen HER2 Nucleus Progesterone receptor Estrogen receptor For More Information In addition to talking with your health care team, you can visit the following websites to find more information on breast cancer and the type that you have: • American Cancer Society: www.cancer.org/cancer/breastcancer • National Cancer Institute: www.cancer.gov/types/breast • Breastcancer.org: www.breastcancer.org Unless otherwise indicated, Genentech Inc. is neither affiliated with nor endorses any of these organizations. The resources listed are meant for informational purposes only. © 2015 Genentech USA, Inc. All rights reserved. HPK/113015/0091 References: American Cancer Society. Breast cancer: detailed guide. http://www.cancer.org/acs/ groups/cid/documents/webcontent/003090pdf.pdf. Updated August 19, 2015. Accessed October 16, 2015. American Cancer Society. Breast Cancer Facts & Figures 2013-2014. Atlanta, GA: American Cancer Society Inc; 2013.